M. Witzenrath (Berlin, Germany), A. Collins (Cheshire, United Kingdom)
LSC - 2019 - RNA degradation is a deficient antiviral mechanism in the asthmatic airway epithelium T. Wong (London, United Kingdom), J. Rynne (London, United Kingdom), P. Howarth (Southampton, United Kingdom), M. Edwards (London, United Kingdom), R. Martinez-Nunez (London, United Kingdom)
|  |
Glucose catabolism by respiration assisted fermentation leading to acetate production has a key contribution to chronic patient airway infection by Haemophilus influenzae J. Garmendia Garcia (Mutilva, Navarra, Spain), N. López-López (Mutilva, Navarra, Spain), B. Euba (Madrid, Spain), G. Almagro (Mutilva, Navarra, Spain), S. Martí (Madrid, Spain), J. Ramos-Vivas (Santander, Spain), J. Pozueta-Romero (Mutilva, Navarra, Spain), M. Barbier (Morgantown WV, United States of America), R. Díez-Martínez (Noain, Navarra, Spain), U. Kappler (St Lucía QLD, Australia)
|   |
Neutrophils and oxidative stress markers may be a useful indicator for initiating chemotherapy in NTM patients S. Oh-Ishi (Ibaraki, Japan), K. Nemoto (Ibaraki, Japan), S. Matumura (Ibaraki, Japan), Y. Kitaoka (Ibaraki, Japan), T. Shimada (Ibaraki, Japan), H. Goto (Ibaraki, Japan), M. Nonaka (Ibaraki, Japan), Y. Sasatani (Ibaraki, Japan), N. Arai (Ibaraki, Japan), K. Hyodo (Ibaraki, Japan), Y. Miura (Ibaraki, Japan), T. Takaku (Ibaraki, Japan), K. Hayashihara (Ibaraki, Japan), S. Fukai (Ibaraki, Japan), T. Saito (Ibaraki, Japan)
|  |
Infectious Human Rhinovirus persists in in vitro human nasal epithelial cells with waning induction of corresponding innate immune signatures activation H. Ong (Singapore, Singapore), K. Tan (Singapore, Singapore), Y. Ong (Singapore, Singapore), M. Thong (Singapore, Singapore), V. Chow (Singapore, Singapore), D. Wang (Singapore, Singapore)
|  |
Macrophage inflammatory responses to Non-typeable Haemophilus influenzae (NTHi) are strain-dependent J. Ackland (Southampton, United Kingdom), K. Osman (Southampton, United Kingdom), C. Spalluto (Southampton, United Kingdom), D. Cleary (Southampton, United Kingdom), M. Christodoulides (Southampton, United Kingdom), T. Wilkinson (Southampton, United Kingdom), K. Staples (Southampton, United Kingdom)
|  |
Dynamics of IFN-ß responses during respiratory viral infection: insights for therapeutic strategies C. Spalluto (Southampton, United Kingdom), A. Watson (Southampton, United Kingdom), C. Mccrae (Gothenburg, Sweden), D. Cellura (Southampton, United Kingdom), H. Burke (Southampton, United Kingdom), D. Cunoosamy (Gothenburg, Sweden), A. Freeman (Southampton, United Kingdom), A. Hicks (Southampton, United Kingdom), M. Hühn (Gothenburg, Sweden), K. Ostridge (Southampton, United Kingdom), K. Staples (Southampton, United Kingdom), O. Vaarala (Gothenburg, Sweden), T. Wilkinson (Southampton, United Kingdom)
|   |
RNA sequencing revealed transcriptomic changes of the human nasal epithelium following human influenza infection K. Tan (Singapore, Singapore), A. Andiappan (Singapore, Singapore), B. Lee (Singapore, Singapore), Y. Yan (Zhuhai, China), J. Liu (Singapore, Singapore), O. Rotzschke (Singapore, Singapore), V. Chow (Singapore, Singapore), D. Wang (Singapore, Singapore)
|   |
Pseudomonas aeruginosa flagellin modulates the immune response in ex vivo lung tissue slices V. Beneke (Hannover, Germany), N. Grahl (Hannover, Germany), O. Danov (Hannover, Germany), S. Konzok (Hannover, Germany), P. Braubach (Hannover, Germany), D. Jonigk (Hannover, Germany), G. Warnecke (Hannover, Germany), O. Pfennig (Hannover, Germany), H. Fieguth (Hannover, Germany), A. Braun (Hannover, Germany), K. Sewald (Hannover, Germany), S. Häußler (Hannover, Germany), S. Wronski (Hannover, Germany)
|  |
Exosomal miRNAs and association with pulmonary tuberculosis E. Mortaz (Tehran, Islamic Republic of Iran), S. D. Alipoor (Tehran, Islamic Republic of Iran), G. Folkerts (Utrecht, Netherlands), J. Garssen (Utrecht, Netherlands), I. Adcock (London, United Kingdom)
|  |
P2X4/P2X7-signalling contributes to bacterial-induced aggravation of COPD S. Schneider (Freiburg, Germany), S. Cicko (Vienna, Austria), A. Zech (Vienna, Austria), M. Hoßfeld (Freiburg, Germany), M. Idzko (Vienna, Austria)
|   |
Extracellular nucleotides contribute to the pathogenesis of viral-induced exacerbations in COPD via P2X4/P2X7-receptor activation S. Schneider (Freiburg, Germany), S. Cicko (Vienna, Austria), A. Zech (Vienna, Austria), M. Hoßfeld (Freiburg, Germany), M. Idzko (Vienna, Austria)
|   |
The role of endothelin-1 in hospitalized patients with community-acquired pneumonia. M. Krykhtina (Dnipro, Ukraine), K. Bielosludtseva (Dnipro, Ukraine), T. Kirieieva (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine), K. Dyagovets (Dnipro, Ukraine)
|   |
Wood smoke effects on epithelial cell lines and human airway cells A. Hansson (Umeå, Sweden), G. Rankin (Umeå, Sweden), O. Uski (Umeå, Sweden), M. Sehlstedt (Umeå, Sweden), J. Bosson (Umeå, Sweden), J. Pourazar (Umeå, Sweden), C. Boman (Umeå, Sweden), R. Lindgren (Umeå, Sweden), N. Garcia Lopez (Umeå, Sweden), A. Behndig (Umeå, Sweden), A. Blomberg (Umeå, Sweden), T. Sandström (Umeå, Sweden), A. Muala (Umeå, Sweden)
|   |
Circulating microRNAs can identify endotypes of community-acquired pneumonia F. Sanz Herrero (Valencia, Spain), S. Vicente Ferrer (Valencia, Spain), M. Briones (Valencia, Spain), M. Martínez (Valencia, Spain), J. Lozada (Valencia, Spain), E. Fernández Fabellas (Valencia, Spain), A. Aibar (Valencia, Spain), S. Ferrer (Valencia, Spain), F. Dasí Fernández (Valencia, Spain)
|   |
Altered pulmonary capillary permeability in immunosuppressed guinea pig infected with serum type 1 Legionella pneumophila X. Cai (Shenyang, China), Y. Chen (Shenyang, China), J. Kang (Shenyang, China)
|  |
Lung vessels thrombosis in patients with lethal severe community-acquired pneumonia: electronic microscopies with 3D modeling K. Bielosludtseva (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine), M. Krykhtina (Dnipro, Ukraine), V. Sipalo (Dnipro, Ukraine), K. Dyagovets (Dnipro, Ukraine)
|   |
Dynamic changes of markers of endothelial function, hemostasis, fibrinolysis and inflammation in hospitalized patients with community-acquired pneumonia K. Bielosludtseva (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine), T. Kirieieva (Dnipro, Ukraine), M. Krykhtina (Dnipro, Ukraine)
|   |
The release of interleukin-26 from alveolar type II cells and its response to stimuli from Gram-negative and Gram-positive bacteria G. Tabacaru (Stockholm, Sweden), A. Linden (Stockholm, Sweden), K. Che (Stockholm, Sweden)
|   |